---
title: "Iwicki Mark T — Ownership Dossier"
canonical: https://whiteintel.dev/entity/fdb6d552-2ba7-5ccc-af20-4687fff71bed
json: https://whiteintel.dev/api/public/dossier/fdb6d552-2ba7-5ccc-af20-4687fff71bed
identifier: sec:0001415537
jurisdiction: US
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# Iwicki Mark T

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001415537`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/fdb6d552-2ba7-5ccc-af20-4687fff71bed  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/fdb6d552-2ba7-5ccc-af20-4687fff71bed  

## Ownership & control

### Holdings / subsidiaries

- **Q32 Bio Inc.** (director) — https://whiteintel.dev/entity/08894b83-faf4-53f2-980d-374ae48ff38a
- **Inhibikase Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/6bc97555-0dbb-5871-b998-473fa2c45117
- **Inhibikase Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/6bc97555-0dbb-5871-b998-473fa2c45117
- **Inhibikase Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/6bc97555-0dbb-5871-b998-473fa2c45117
- **KALA BIO, Inc.** (officer) — https://whiteintel.dev/entity/e0248354-f35e-5a0a-b45d-19278abdce0e
- **Q32 Bio Inc.** (director) — https://whiteintel.dev/entity/08894b83-faf4-53f2-980d-374ae48ff38a
- **Inhibikase Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/6bc97555-0dbb-5871-b998-473fa2c45117
- **Inhibikase Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/6bc97555-0dbb-5871-b998-473fa2c45117
- **KALA BIO, Inc.** (director) — https://whiteintel.dev/entity/e0248354-f35e-5a0a-b45d-19278abdce0e
- **Akero Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b
- **Merus N.V.** (director) — https://whiteintel.dev/entity/94da0ca6-a73e-5895-83fb-b50de1f38026
- **Third Harmonic Bio, Inc.** (director) — https://whiteintel.dev/entity/e1b6fe48-1324-5dbb-bd90-38bb4c119af2
- **KALA BIO, Inc.** (officer) — https://whiteintel.dev/entity/e0248354-f35e-5a0a-b45d-19278abdce0e
- **AEROVATE THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/0498d804-2189-5885-b4d8-f0171a454d64
- **PULMATRIX, INC.** (director) — https://whiteintel.dev/entity/50136411-1b79-51e5-96e5-fc66e5d6e3f8
- **AIMMUNE THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/066a4294-db20-535c-9182-fd207c4cc627
- **KALA BIO, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/e0248354-f35e-5a0a-b45d-19278abdce0e
- **SEPRACOR INC /DE/** (officer) — https://whiteintel.dev/entity/ee1fe6d9-5ffb-590e-b7e7-4e4a162edbf9

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Iwicki Mark T**. Human view: https://whiteintel.dev/entity/fdb6d552-2ba7-5ccc-af20-4687fff71bed · Structured JSON: https://whiteintel.dev/api/public/dossier/fdb6d552-2ba7-5ccc-af20-4687fff71bed._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._